Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519213) titled 'Postoperative Hormonal Therapy and Recurrence After Surgery for Ovarian Endometrioma' on April 2.

Study Type: Observational

Primary Sponsor: Guangdong Women and Children Hospital

Condition: Ovarian Endometrioma Endometriosis

Recruitment Status: Not recruiting

Date of First Enrollment: September 1, 2025

Target Sample Size: 1121

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07519213

Published by HT Digital Content Services with permission from Health Daily Digest....